CellmAbs

CellmAbs is a rapidly growing biotechnology company dedicated to developing cancer therapeutics, aiming to provide cancer immunotherapies that prevent tumor cells from evading the immune system. With an experienced international team, and based on world-class understanding of cancer-specific glycan targets, the company has developed multiple preclinical candidates for solid tumors.